Ventricular unloading, tissue angiotensin II, matrix modulation, and function during left ventricular assist device support.
Jugdutt
Bodh I
BI
Butler
Craig
C
D000804:Angiotensin II / Q000187:drug effects / Q000378:metabolism*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D005109:Extracellular Matrix / Q000187:drug effects / Q000378:metabolism*; D005260:Female; D005544:Forecasting; D006333:Heart Failure / Q000188:drug therapy* / Q000401:mortality / Q000601:surgery; D006353:Heart-Assist Devices; D006801:Humans; D008297:Male; D020781:Matrix Metalloproteinase 1 / Q000187:drug effects / Q000378:metabolism; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D013318:Stroke Volume / Q000187:drug effects; D016019:Survival Analysis; D020257:Ventricular Remodeling / Q000187:drug effects
D000806:Angiotensin-Converting Enzyme Inhibitors; D000804:Angiotensin II; D020781:Matrix Metalloproteinase 1